[{"Assets_0_Q2_USD":116344000.0,"CommonStockSharesOutstanding_0_Q2_shares":110370000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-51499000.0,"NetIncomeLoss_1_Q2_USD":-37629000.0,"NetIncomeLoss_2_Q2_USD":-68683000.0,"StockholdersEquity_0_Q2_USD":-9193000.0,"Ticker":"BCRX","CIK":"882796","name":"BIOCRYST PHARMACEUTICALS INC","OfficialName":"BioCryst Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1887243586.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20190808"}]